Comunicati Stampa
Cibi e Bevande

Ready-to-Use Therapeutic Food Market to Expand at 5.7% CAGR, Reaching $800.6 Million by 2034: Fact.MR Analysis

Increased demand for solid RUTF products is attributed to their easy availability in the form of candy bars, biscuits, and powder. Thereby, it is comparatively easier for individuals to consume them directly or even with drinking water for use as a porridge. These therapeutic products are comparatively easy to carry and help in meeting the nutritional requirements of those who require them the most. Increased demand for solid RUTF products is attributed to their easy availability in the form of...
ROCKVILLE, Md., (informazione.it - comunicati stampa - cibi e bevande)

Increased demand for solid RUTF products is attributed to their easy availability in the form of candy bars, biscuits, and powder. Thereby, it is comparatively easier for individuals to consume them directly or even with drinking water for use as a porridge. These therapeutic products are comparatively easy to carry and help in meeting the nutritional requirements of those who require them the most.

The United States is one of the prominent countries actively involved in the manufacturing as well as supply of ready-to-use therapeutic food products. Growing emphasis on home-based treatment for severe and moderate malnourished children is driving demand for RUTF globally.

a Fact.MR analyst.

Worldwide demand for RUTF products from UNICEF is projected to accelerate at a CAGR of 5.4% and reach a market value of US$ 263.4 million by 2034-end. UNICEF is actively working at the forefront against malnutrition and hunger among the global pediatric population. It is procuring a noteworthy amount of RUTF for fulfilling the nutritional needs of needy people globally. In addition, it is also working to establish therapeutic centers for saving lives and supporting families in poverty-stricken regions and countries.

Some of the key suppliers of ready-to-use therapeutic food are GC Rieber Compact AS, Power Foods Tanzania, GC Mana Nutritive Aid Products, Hilina, Inno Faso , Nuflower Foods and Nutrition Pvt., Samil Industrial, Kaira District Cooperative, and Tabatchnik Fine Foods.

According to a newly published study by Fact.MR, a market research and competitive intelligence provider, North America is projected to capture 24.3% of the global market share by 2034. The United States stands out as a key player in the North American region, actively engaged in the production and supply of Ready-to-Use Therapeutic Foods (RUTF) products.

China is projected to hold 47.5% of the East Asian market revenue share by the end of 2034. This growth is driven by increased demand for ready-to-use therapeutic food (RUTF) products, supported by government initiatives providing funding for children suffering from malnutrition and other health issues. Additionally, the Chinese government is launching new programs to combat malnutrition among children.

Japan is expected to contribute 29.4% of the East Asian market share by 2034. The steady increase in demand for RUTF in Japan is attributed to the rising production of supplement products to meet nutritional needs. Moreover, the growing use of RUTF products due to hectic lifestyles is encouraging manufacturers to develop nutrient-rich options.

 

Fact.MR, in its new offering, presents an unbiased analysis of the ready-to-use therapeutic food market, presenting historical demand data (2019 to 2023) and forecast statistics for the period (2024 to 2034).

The study divulges essential insights into the market based on type (solid [powder/blends, biscuits/bars], paste, drinkable) and end-user (United National International Children's Emergency Fund [UNICEF], World Food Program [WEP], government organizations, non-government organizations [NGOs]), across seven major regions of the world ( North America , Latin America , Western Europe , Eastern Europe , East Asia , South Asia & Pacific, and MEA).

 is projected to grow at 7.9% CAGR and reach a value of $201.75 billion by 2033.

is forecasted to reach $163 billion in 2022 and is poised to expand to $351 billion by 2032.

is projected to grow to $41.1 billion by 2033, with a 6.3% annual growth rate over the next decade.

is estimated to reach $1,495 billion by 2032, increasing at 6.1% CAGR.

is expected to grow to $156.3 million by 2024 and reach $358.5 million by 2034, with a CAGR of 8.7%.

is expected to reach $4.1 billion by 2034, Growing at 7.4 % CAGR.

 to surge from $212.9M in 2024 to $569.2M by 2034, driven by 9.4% CAGR, marking substantial growth.

is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay competitive.


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team:  sales@factmr.com
Follow Us:  LinkedIn  |  Twitter  |  Blog

 

View original content: https://www.prnewswire.co.uk/news-releases/ready-to-use-therapeutic-food-market-to-expand-at-5-7-cagr-reaching-800-6-million-by-2034-factmr-analysis-302175727.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili